Jinarc Description

Jinarc 15 mg tablets are blue, triangular (major axis: 6.58 mm, minor axis: 6.20 mm), shallow-convex, debossed with "OTSUKA" and "15" on one side.
Jinarc 30 mg tablets are blue, round (diameter: 8 mm), shallow-convex, debossed with "OTSUKA" and "30" on one side.
Jinarc 45 mg tablets are blue, square (6.8 mm on a side, major axis 8.2 mm), shallow-convex, debossed with "OTSUKA" and "45" on one side.
Jinarc 60 mg tablets are blue, modified rectangular (major axis 9.9 mm, minor axis 5.6 mm), shallow-convex, debossed with "OTSUKA" and "60" on one side.
Jinarc 90 mg tablets are blue, pentagonal (major axis 9.7 mm, minor axis 9.5 mm), shallow-convex, debossed with "OTSUKA" and "90" on one side.
Jinarc 30 mg tablets: Each 30 mg tablet contains 30 mg of tolvaptan.
Excipient(s) with known effect: Each 30 mg tablet contains approximately 70 mg lactose (as monohydrate).
Jinarc 45 mg + 15 mg tablets: Each 45 mg tablet contains 45 mg of tolvaptan. Each 15 mg tablet contains 15 mg of tolvaptan.
Excipient(s) with known effect: Each 45 mg tablet contains approximately 12 mg lactose (as monohydrate). Each 15 mg tablet contains approximately 35 mg lactose (as monohydrate).
Jinarc 60 mg + 30 mg tablets: Each 60 mg tablet contains 60 mg of tolvaptan. Each 30 mg tablet contains 30 mg of tolvaptan.
Excipient(s) with known effect: Each 60 mg tablet contains approximately 16 mg lactose (as monohydrate). Each 30 mg tablet contains approximately 70 mg lactose (as monohydrate).
Jinarc 90 mg + 30 mg tablets: Each 90 mg tablet contains 90 mg of tolvaptan. Each 30 mg tablet contains 30 mg of tolvaptan.
Excipient(s) with known effect: Each 90 mg tablet contains approximately 24 mg lactose (as monohydrate). Each 30 mg tablet contains approximately 70 mg lactose (as monohydrate).
Excipients/Inactive Ingredients: Maize starch, Hydroxypropylcellulose, Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Indigo carmine (E132) aluminium lake.